loader2
Login Open ICICI 3-in-1 Account
Open ICICI 3-in-1 Account

Procter & Gamble Hygiene and Health Care Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Procter & Gamble Hygiene & Healthcare Ltd. 06 Nov 2025 14:06 PM
Result PDF

Q2FY26 Quarterly Result Announced for Procter & Gamble Hygiene & Healthcare Ltd.

Personal Products company Procter & Gamble Hygiene & Healthcare announced Q2FY26 results

  • Company delivered sales of Rs 1,150 crore, reporting a growth of 1% versus year ago.
  • Profit After Tax (PAT) was Rs 210 crore.

Kumar Venkatasubramanian, Managing Director, Procter & Gamble Hygiene & Health Care, said: “In an evolving and dynamic external environment, our team came together to execute our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority across product performance, packaging, brand communication, retail execution and consumer and customer value productivity, constructive disruption and an agile and accountable organization. We know that this strategy is the right one for us to deliver sustainable, balanced growth and value creation.”

Result PDF

Result PDF

Personal Products company Procter & Gamble Hygiene & Healthcare announced Q3FY25 results

  • The company delivered a balanced growth in the quarter, with sales of Rs 1,248 crore, up 10% versus year ago driven by a robust portfolio.
  • Profit After Tax (PAT) for the quarter was Rs 269 crore, up 17% versus year ago led by strong topline growth.
  • The Company has announced an interim dividend of Rs 110 per equity share for FY25.

Kumar Venkatasubramanian, Managing Director, Procter & Gamble Hygiene and Health Care, said: “The Company has delivered a strong double-digit growth across both topline and bottom line in the quarter. This has been led by our continued focus on delighting all consumers with superior propositions and executing the integrated growth strategy– a focused product portfolio of daily use categories where performance drives brand choice, superiority (of product performance, packaging, brand communication, retail execution and consumer and customer value), productivity, constructive disruption, and an agile and accountable organization. Our strategy has enabled these solid results and is a foundation for balanced growth and value creation.”

Result PDF

Personal Products company Procter & Gamble Hygiene & Healthcare announced Q1FY25 results

  • Total sales of Rs 1,133 crore.
  • Profit After Tax (PAT) for Q1FY25 was Rs 212 crore, change 1% compared to Q1FY24.

Venkatasubramanian, Managing Director, Procter & Gamble Hygiene and Health Care, said: “We have continued to focus on delighting consumers with superior propositions, and driving the integrated growth strategy– a focused product portfolio of daily use categories where performance drives brand choice, superiority (of product performance, packaging, brand communication, retail execution and consumer and customer value), productivity, constructive disruption, and an agile and accountable organization – which we remain committed to.”

Result PDF

Personal Products  company Procter & Gamble Hygiene & Healthcare announced Q3FY24 results:

Financial Highlights:
- Procter & Gamble Hygiene and Health Care reported sales of Rs 998 crore.
- There was a 13% increase in sales YoY.
- The Profit After Tax was Rs 154 crore.
- PAT saw a 50% operational increase.
- Despite the operational rise, reported profit after tax was down by 6% versus the previous year, attributable to one-time tax impacts.

LV Vaidyanathan, Managing Director, commented on the performance stating, "We delivered strong top-line growth despite a challenging operating environment, driven by superior products that are delighting and serving consumers' evolving needs. We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority across product performance, packaging, brand communication, retail execution and consumer and customer value - productivity, constructive disruption, and an agile and accountable organization. We are confident that these strategies will help us navigate the mid-term and deliver balanced growth and value creation.”

Result PDF

Personal Products company Procter & Gamble Hygiene & Healthcare announced Q2FY24 results:

  • In a challenging operating environment, the Company reported sales of Rs 1,131 crore, at par vs year ago.
  • Profit After Tax (PAT) for the quarter was Rs 229 crore, up 10% versus a year ago. Excluding the impact of one-time items in the quarter, PAT was up 15% versus a year ago.
  • The profit growth is led by product price-mix, productivity, and moderating cost inflation versus the base period.
  • The Board has declared an interim dividend of Rs 160 per equity share for the financial year 2023-24.
  • The company is celebrating its 60th year since commencement of operation. This interim dividend includes a one-time special dividend of Rs 60 per equity share to commemorate this special occasion.

LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care shared, “The quarter has remained challenging amidst a difficult operating environment. We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, and superiority —across product performance, packaging, brand communication, retail execution, and consumer and customer value — productivity, constructive disruption, and an agile and accountable organization. We are confident that these strategies will help us navigate the mid-term and deliver balanced growth and value creation.”

 

Result PDF

Personal Products company Procter & Gamble Hygiene & Healthcare announced Q1FY24 results:

  • During the quarter, the company delivered strong growth with sales of Rs 1,138 crore, up 9% YoY driven by a superior retail execution and integrated growth strategy.
  • Profit After Tax (PAT) for the quarter was Rs 211 crore, up 36% YoY led by acceleration of volume growth coupled with product price mix and productivity.
  • Sales up 9% YoY.

LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care shared, “We delivered a strong top and bottom-line growth in the quarter, by executing our integrated strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority — across product performance, packaging, brand communication, retail execution and consumer and customer value —productivity, constructive disruption, and an agile and accountable organization. Our team’s execution of these strategies has enabled us to build momentum in the first quarter, and we are confident that these strategies will help us deliver balanced growth and value creation.”

 

Result PDF

Personal Products company Procter & Gamble Hygiene & Healthcare announced Q3FY23 (Year ending Jun'23) results:

  • The company delivered sales of Rs 883 crore, down 1% operationally vs a year ago behind the Omicron-driven demand surge in the healthcare portfolio in the base period
  • The company continued to make sequential progress in profit growth with Profit After Tax (PAT) at Rs 165 crore, up 17% operationally vs a year ago fueled by premiumization and productivity interventions
  • The period also saw an impact on sales of -8% due to one-time non-operating income in the base period. With this, the reported sales were down 9% vs a year ago
  • Reported profit after tax was up 60% vs a year ago due to one-time tax impacts 

LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care, shared, “Despite a challenging operating environment, we delivered a resilient performance in the quarter, recording a strong sequential growth in profit. This has been possible behind our integrated growth strategies of a focused product portfolio, superiority, productivity, constructive disruption, and an agile and accountable organization structure. We believe that these continue to remain the right strategies for us to navigate the near-term challenges and drive balanced growth.”

 

 

Result PDF

Personal products firm Procter & Gamble Hygiene & Healthcare announced Q3FY23 results:

  • Q3FY23:
    • The Company continued to make sequential progress in the quarter and delivered sales of Rs 1,137 crores, up 4% vs a year ago behind its trusted product portfolio and superior retail execution.
    • Profit After Tax (PAT) was Rs 207 crore, down 2% vs a year ago largely behind commodity cost inflation. Compared to the corresponding pre-covid quarter three years ago, company sales are up 32% and PAT is up 53%.
    • The Board of Directors declared an interim dividend of Rs 80 on every equity share Rs 10. The record date for the dividend will be February 8, 2023.

LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. shared, “Despite external headwinds and macro-economic environment, we delivered a resilient performance as this quarter recorded sequential progress across topline and bottom line, enabled by the strength of our brands and execution excellence. This has been possible behind our integrated growth strategies of a focused product portfolio, superiority, productivity, constructive disruption, and an agile and accountable organization. We believe that these are the right strategies for us to navigate the near-term challenges and drive balanced growth.” 

Result PDF

Personal Products firm Procter & Gamble Hygiene & Healthcare announced Q1FY23 Result :

  • Sales up 9% for the fiscal ended June 30, 2022
  • Procter & Gamble Hygiene and Health Care Ltd. today announced its financial results for the fiscal and quarter ended June 30, 2022. Despite unprecedented headwinds from macroeconomic challenges and softening consumption trends, the Company continued to grow and delivered a resilient performance in the fiscal with sales of Rs 3,901 crore, up 9% versus year ago, behind the proven superiority strategy and strong brand fundamentals. Profit After Tax (PAT) was Rs 576 crore, down 12% versus year ago, largely behind commodities inflation which was significantly countered by cost productivity and pricing in the current year. Compared to the fiscal two years ago, the Company’s sales are up 30% and Profit After Tax (PAT) is up 33%.
  • For the quarter ended June 30, 2022, the company delivered sales of Rs 776 crore, down 1% versus year ago. Profit After Tax (PAT) was Rs 43 crore, down 13% versus year ago largely behind commodity cost inflation. For the quarter, both feminine care and healthcare businesses continue to grow and maintain category leadership.

LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, “The operating environment continues to be marked by unprecedented headwinds and commodity fluctuations. Despite these challenges, we remain resilient, agile, and committed to serve Indian consumers, delivering sequential sales growth this year. The execution of our integrated strategies of a strong portfolio, superiority, productivity, constructive disruption, and an agile and accountable organization structure, has empowered us to deliver these consistent results. Our strategy is fueled by balancing innovation and industry-leading practices, while driving productivity in everything we do.” He further added, “While the unprecedented market challenges and uncertainties remain in the near-term, we will continue to stay focused on our strategy of driving superiority and productivity and enabled by the strength of our organization and culture, to deliver balanced growth and value creation.”

Result PDF

Personal Products company Procter & Gamble Hygiene & Healthcare declares Q4FY22 result:

  • Procter & Gamble Hygiene and Health Care Ltd. delivered sales of Rs 973 crores, up 28% vs year ago driven by strong brand fundamentals, strength of its trusted product portfolio, strong retail execution and a one-time other income during the quarter from intercompany sale of inventory.
  • Excluding the one-time income, comparable sales are up 17% vs year ago. Profit After Tax (PAT) was Rs 103 crores, up 5% driven by continued focus on productivity and a one-time hurt due to retrospective tax law change. Excluding this one-time impact, PAT was up 20% vs year ago, despite commodity inflation

Madhusudan Gopalan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, “In a challenging market environment, we recorded strong double-digit sales growth driven by strong brand fundamentals and improved market execution. Excluding the one-time impact, our productivity efforts led to a strong double digit profit growth. As we navigate the challenging cost environment, we will continue to focus on improving productivity by leveraging advertising and promotion analytics, strengthening our product mix and driving supply chain efficiencies. In the long-term, we will continue to focus on driving balanced top and bottom-line growth enabled by our superiority strategy, improving productivity, leading constructive disruption, and strengthening our organization and culture.”

Result PDF

Trending News

Silver price hits new high

As per media sources, silver prices reached an all-time high of $67 per ounce for the first time yesterday.

Published on 22-Dec-2025 09:13

Krishna Institute sets up super speciality hospital

Krishna Institute of Medical Sciences Limited has entered into a lease and licence agreement with Andhra Mahila Sabha to lease around 1.168 acres of land in Chennai for setting up a super speciality hospital. 

Published on 22-Dec-2025 09:12

Delhi cracks down on liquor cartels

According to media reports, Delhi government is cracking down on liquor cartels even as the top selling liquor brands remain the same in the national capital as during the previous Aam Aadmi Party (AAP) regime. 

Published on 22-Dec-2025 09:11

Titan aims for $1 billion watch sales

Titan is optimistic for its watch business, which is expected to touch the $1 billion sales mark in the next two years, led by factors such as premiumisation, retail footprint expansion and growth of the international business division. 

Published on 22-Dec-2025 09:10

Shree Cement gets greenlight for ₹2,000 cr cement plant

As per media reports, Shree Cement has signed an LoI with Maharashtra to set up a 2 mtpa cement plant in Chandrapur district, Maharashtra with an investment of Rs 2000 crore. 

Published on 22-Dec-2025 09:09

US President signs national defense act

The US President has signed the National Defense Authorisation Act, an amended version of the US Biosecure Act. 

Published on 22-Dec-2025 09:08

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app
✕
Application status